The p38 mitogen-activated protein kinase inhibitor SB203580 antagonizes the inhibitory effects of interleukin-1β on long-term potentiation in the rat dentate gyrus in vitro
- 21 June 1999
- journal article
- Published by Elsevier BV in Neuroscience
- Vol. 93 (1), 57-69
- https://doi.org/10.1016/s0306-4522(99)00100-1
Abstract
No abstract availableKeywords
Funding Information
- Health Research Board
- University College Dublin
This publication has 56 references indexed in Scilit:
- Molecular mechanisms that underlie structural and functional changes atthe postsynaptic membrane duringsynaptic plasticityProgress in Neurobiology, 1998
- Enhancement of Fibroblast Collagenase (Matrix Metalloproteinase-1)Gene Expression by Ceramide Is Mediated by Extracellular Signal-regulated and Stress-activated Protein Kinase PathwaysPublished by Elsevier BV ,1998
- Reactivating Kinase/p38 Phosphorylates τ Protein In VitroJournal of Neurochemistry, 1997
- p38 Mitogen-activated Protein Kinase Down-regulates Nitric Oxide and Up-regulates Prostaglandin E2 Biosynthesis Stimulated by Interleukin-1βPublished by Elsevier BV ,1997
- Ceramide signaling in apoptosisBritish Medical Bulletin, 1997
- Interleukin 1 (IL1) and tumour necrosis factor (TNF) signal transductionPhilosophical Transactions Of The Royal Society B-Biological Sciences, 1996
- PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in VivoJournal of Biological Chemistry, 1995
- SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin‐1FEBS Letters, 1995
- Interleukin-1β inhibits Ca2+ channel currents in hippocampal neurons through protein kinase CEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- cPLA2 is phosphorylated and activated by MAP kinaseCell, 1993